Fig. 4
From: Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
Copyright 2020, Wiley–VCH. c The therapeutic mechanism of MnO2-Au@SiO2 nanoplatforms in solid tumors [49]. d In vivo toxicology assessment of MnO2-Au@SiO2 NPs; the relative tumor volume and photographs of tumor-bearing mice and tumor tissues from tumor-bearing mice after different treatment. Reproduced with permission. [49] Copyright 2020, Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature. e The mechanism of MnWOx leads to increase ROS production [50]. f Schematic of the in vivo SDT procedure on mice and fluorescence images of DCFH-DA-stained tumor slices collected from mice 24 h post-treatment and tumor growth curves and average weights of tumors after various treatments [50]. g Distribution of W levels in mice at different times based on inductively coupled plasma measurement. Reproduced with permission. [50] Copyright 2019, Wiley–VCH